Speech-Language Pathologists in N Charleston, SC Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Joanna Wolff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3300 Creola Rd, N Charleston, SC 29420 Phone: 843-767-5905

Littles Of The Lowcountry Therapy Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4412 S Rhett Ave, N Charleston, SC 29405 Phone: 937-479-1640

Slp Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2749 Star Dr, N Charleston, SC 29406 Phone: 843-509-2557    Fax: 843-763-9595

Cheryl Gesser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4390 Belle Oaks Dr, Suite 120, N Charleston, SC 29405 Phone: 843-571-2700

Danielle Watts Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4390 Belle Oaks Dr, Suite 120, N Charleston, SC 29405 Phone: 866-571-2700

News Archive

Mothers who are concerned about their own health may unwittingly be passing their anxieties on to their children

A new study of parenting suggests that mothers who suffer from certain illnesses like Irritable Bowel Syndrome are more likely to take their babies to the doctors for a range of minor problems.

Researchers identify brain circuits used in sensation of touch

The ability to tactually recognize fine spatial details, such as the raised dots used in braille, is especially important to those who are blind.

Cord Blood America to open cryogenic research and storage laboratory in Las Vegas

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it is opening its new Corporate headquarters and cryogenic research and storage laboratory in Las Vegas, as planned, the first week of October.

Neuralstem announces results from Phase I trial using NSI-566 spinal cord stem cells in treatment of ALS

Neuralstem, Inc. (NYSE MKT: CUR) announced that the final results from the Phase I safety trial using NSI-566 spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) were published in the peer-reviewed journal, "Annals of Neurology".

Evolvent Technologies awarded contract to increase Veterans Affairs clinician access to DoD information

Evolvent Technologies, Inc. (Evolvent), a leading provider of healthcare information technology to the federal government, announced today that it was awarded a contract with the Department of Defense (DoD) Military Health Services for enhancements to the Bidirectional Health Information Exchange (BHIE) to further increase Veterans Affairs (VA) clinician access to DoD information on a shared patient population.

Read more Medical News

› Verified 1 days ago